Does active surveillance of serious and life-threatening adverse drug reactions improve reporting?
Paediatr Child Health
.
2011 Nov;16(9):532-4.
doi: 10.1093/pch/16.9.532.
Authors
Margaret Zimmerman
1
,
Danielle Grenier
,
Miriam Levitt
Affiliation
1
Patient Safety Section, Therapeutic Effectiveness and Policy Bureau, Marketed Health Products Directorate, Health Canada;
PMID:
23115488
PMCID:
PMC3223884
DOI:
10.1093/pch/16.9.532
No abstract available